Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Bionano Genomics Q4 Sales $10.721M Beat $10.585M Estimate

Author: Benzinga Newsdesk | March 05, 2024 05:18pm
Bionano Genomics (NASDAQ:BNGO) reported quarterly sales of $10.721 million which beat the analyst consensus estimate of $10.585 million by 1.28 percent. This is a 30.51 percent increase over sales of $8.215 million the same period last year.

Posted In: BNGO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist